Yu, A L <br/><br/>
Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jun 1998 
 - 2169-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1998.16.6.2169  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Child<br/>Child, Preschool<br/>Complement C3--analysis<br/>Complement C4--analysis<br/>Complement Hemolytic Activity Assay<br/>Female<br/>Fluorescent Antibody Technique, Indirect<br/>Gangliosides--immunology<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Mice<br/>Neuroblastoma--metabolism<br/>Osteosarcoma--therapy<br/>Pain--chemically induced<br/>Recombinant Fusion Proteins--administration & dosage<br/>Treatment Outcome